Japan Hypertension Society Sets Up Ethics Committee In Response To Diovan Problem
This article was originally published in PharmAsia News
Executive Summary
The Japanese Society of Hypertension has established an ethics committee in response to the problems with clinical trials for Novartis’ drug Diovan (valsartan).